Tuberculosis: Lights and shadows in the current diagnostic landscape

New Microbiologica

Volumn 36, Issue 2, 2013, Pages 111-120

  Norbis, Luca ^a   Miotto, Paolo ^a   Alagna, Riccardo ^a   Cirillo, Daniela M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Diagnosis; Diagnostic algorithms; Point of need testing; Tuberculosis

Indexed keywords

ANIMAL; DIAGNOSTIC TEST; EVALUATION; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; REVIEW; TUBERCULOSIS;

ANIMALS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84878878812     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. ABRAMOVITZ M., ZELNICK J. (2010). Double jeopardy: the impact of neoliberalism on care workers in the United States and South Africa. Int. J. Health. Serv. 40, 97-117.
2. AMANATIDOU V., SYRIDOU G., MAVRIKOU M., TSOLIA M.N. (2012). Latent tuberculosis infection in children: diagnostic approaches. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1285-1294.
3. BATZ H.G., CASENGHI M., COOKE G.S., HARGREAVES S., REID S.D., SYED J. (2012). New research and development strategy for tuberculosis diagnostics urgently needed. Lancet Infect. Dis. 12, 584-585.
4. BOEHME C.C., NABETA P., HILLEMANN D., NICOL M.P., SHENAI S., KRAPP F., ALLEN J., TAHIRLI R., BLAKEMORE R., RUSTOMJEE R., MILOVIC A., JONES M., O'BRIEN S.M., PERSING D.H., RUESCH-GERDES S., GOTUZZO E., RODRIGUES C., ALLAND D., PERKINS M.D. (2010). Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363, 1005-1015.
5. BWANGA F., HOFFNER S., HAILE M., JOLOBA M.L. (2009). Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 9, 67.
6. DOBLER C.C., MCDONALD S.P., MARKS G.B. (2011). Risk of tuberculosis in dialysis patients: a nationwide cohort study. PLoS One. 6, e29563.
7. FARMER. (2005). Pathologies of power. Health, human rights, and the new war on the poor. Berkeley: University of California press.
8. FU Y., YI Z., WU X., LI J., XU F. (2011). Circulating microRNAs in patients with active pulmonary tuberculosis. J. Clin. Microbiol. 49, 4246-4251.
9. HARRIES A.D., ZACHARIAH R., CORBETT E.L., LAWN S.D., SANTOS-FILHO E.T., CHIMZIZI R., HARRINGTON M., MAHER D., WILLIAMS B.G., DE COCK K.M. (2010). The HIV-associated tuberculosis epidemic - when will we act? Lancet. 375, 1906-1919.
10. HOLTY J.E., GOULD M.K., MEINKE L., KEEFFE E.B., RUOSS S.J. (2009). Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl. 15, 894-906.
11. HORSBURGH C.R., JR., O'DONNELL M., CHAMBLEE S., MORELAND J.L., JOHNSON J., MARSH B.J., NARITA M., JOHNSON L.S., VON REYN C.F. (2010). Revisiting rates of reactivation tuberculosis: a population-based approach. Am. J. Respir. Crit. Care Med. 182, 420-425.
12. KALOKHE A.S., SHAFIQ M., LEE J.C., RAY S.M., WANG Y.F., METCHOCK B., ANDERSON A.M., LY T.N.M. (2012). Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing. Am. J. Med. Sci.
13. KIM S.Y., JUNG G.S., KIM S.K., CHANG J., KIM M.S., KIM Y.S., KANG Y.A., JOO D.J. (2012). Comparison of the tuberculin skin test and interferon-gamma release assay for the diagnosis of latent tuberculosis infection before kidney transplantation. Infection.
14. KOH WJ K.Y., KIM C.K., PARK K.S., LEE N.Y. (2012). Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann. Lab. Med. 32.
15. LANGE C., SESTER M. (2012). TB or not TB: the role of immunodiagnosis. Eur. J. Immunol. 42, 2840-2843.
16. LAWN S.D., ZUMLA A.I. (2011). Tuberculosis. Lancet. 378, 57-72.
17. LEUNG C.C., RIEDER H.L., LANGE C., YEW W.W. (2011). Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur. Respir. J. 37, 690-711.
18. LINAS B.P., WONG A.Y., FREEDBERG K.A., HORSBURGH C.R. JR. (2011). Priorities for screening and treatment of latent tuberculosis infection in the United States. Am. J. Respir. Crit. Care Med. 184, 590-601.
19. LONNROTH K., JARAMILLO E., WILLIAMS B.G., DYE C., RAVIGLIONE M. (2009). Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc. Sci. Med. 68, 2240-2246.
20. MACK U., MIGLIORI G.B., SESTER M., RIEDER H.L., EHLERS S., GOLETTI D., BOSSINK A., MAGDORF K., HOLSCHER C., KAMPMANN B., AREND S.M., DETJEN A., BOTHAMLEY G., ZELLWEGER J.P., MILBURN H., DIEL R., RAVN P., COBELENS F., CARDONA P.J., KAN B., SOLOVIC I., DUARTE R., CIRILLO D.M., LANGE C., TBNET. (2009). LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur. Respir. J. 33, 956-973.
21. MARAIS B.J., GIE R.P., SCHAAF H.S., HESSELING A.C., OBIHARA C.C., NELSON L.J., ENARSON D.A., DONALD P.R., BEYERS N. (2004). The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int. J. Tuberc. Lung. Dis. 8, 278-285.
22. MATSEKE G., PELTZER K., LOUW J., NAIDOO P., MCHUNU G., TUTSHANA B. (2012). Inconsistent condom use among public primary care patients with tuberculosis in South Africa. Scientific World Journal, 2012, 501807.
23. MAUCH V., WOODS N., KIRUBI B., KIPRUTO H., SITIENEI J., KLINKENBERG E. (2011). Assessing access barriers to tuberculosis care with the tool to Estimate Patients' Costs: pilot results from two districts in Kenya. BMC Public. Health. 11, 43.
24. MCNERNEY R., MAEURER M., ABUBAKAR I., MARAIS B., MCHUGH T.D., FORD N., WEYER K., LAWN S., GROBUSCH M.P., MEMISH Z., SQUIRE S.B., PANTALEO G., CHAKAYA J., CASENGHI M., MIGLIORI G.B., MWABA P., ZIJENAH L., HOELSCHER M., COX H., SWAMINATHAN S., KIM P.S., SCHITO M., HARARI A., BATES M., SCHWANK S., O'GRADY J., PLETSCHETTE M., DITUI L., ATUN R., ZUMLA A. (2012). Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J. Infect. Dis. 205 (Suppl. 2): S147-158.
25. MINGUEZ S., LATORRE I., MATEO L., LACOMA A., DIAZ J., OLIVE A., DOMINGUEZ J. (2012). Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment. Clin. Rheumatol. 31, 785-794.
26. MIOTTO P., SALERI N., DEMBELE M., OUEDRAOGO M., BADOUM G., PINSI G., MIGLIORI G.B., MATTEELLI A., CIRILLO D.M. (2009). Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. BMC Infect. Dis. 9, 142.
27. NANSERA D., BAJUNIRWE F., KABAKYENGA J., ASIIMWE P.K., MAYANJA-KIZZA H. (2010). Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district. Afr. Health. Sci. 10, 312-319.
28. ONGUGO K., HALL J., ATTIA J. (2011). Implementing tuberculosis control in Papua New Guinea: a clash of culture and science? J. Community Health. 36, 423-430.
29. PAI M., O'BRIEN R. (2008). New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin. Respir. Crit. Care Med. 29, 560-568.
30. PEARCE E.C., WOODWARD J.F., NYANDIKO W.M., VREEMAN R.C., AYAYA S.O. (2012). A systematic review of clinical diagnostic systems used in the diagnosis of tuberculosis in children. AIDS Res. Treat. 2012, 401896.
31. PEREZ-VELEZ C.M., MARAIS B.J. (2012). Tuberculosis in children. N. Engl. J. Med. 367, 348-361.
32. POLLOCK K.M., TAM H., GRASS L., BOWES S., COOKE G.S., PAREEK M., MONTAMAT-SICOTTE D., KAPEMBWA M., TAYLOR G.P., LALVANI A. (2012). Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open. 2, e000762.
33. RAVIGLIONE M.C., PIO A. (2002). Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet. 359, 775-780.
34. RAVIGLIONE M.C., UPLEKAR M.W. (2006). WHO's new Stop TB Strategy. Lancet. 367, 952-955.
35. RICKS P.M., CAIN K.P., OELTMANN J.E., KAMMERER J.S., MOONAN P.K. (2011). Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009. PLoS One. 6, e27405.
36. SALERI N., BADOUM G., OUEDRAOGO M., DEMBELE S.M., NACANABO R., BONKOUNGOU V., CIRILLO D., PINSI G., MATTEELLI A. (2010). Extensively drug-resistant tuberculosis, Burkina Faso. Emerg. Infect. Dis. 16, 840-842.
37. SCHAAF H.S., COLLINS A., BEKKER A., DAVIES P.D. (2010). Tuberculosis at extremes of age. Respirology. 15, 747-763.
38. SCHLUGER N.W., BURZYNSKI J. (2010). Recent advances in testing for latent TB. Chest. 138, 1456-1463.
39. SHARMA S.K. MOHAN A. (2004). Extrapulmonary tuberculosis. Indian. J. Med Res. 120, 316-353.
40. SIA I.G., WIELAND M.L. (2011). Current concepts in the management of tuberculosis. Mayo Clin. Proc. 86, 348-361.
41. SOMMA D., THOMAS B.E., KARIM F., KEMP J., ARIAS N., AUER C., GOSONIU G.D., ABOUIHIA A., WEISS M.G. (2008). Gender and socio-cultural determinants of TB-related stigma in Bangladesh, India, Malawi and Colombia. Int. J. Tuberc. Lung Dis. 12, 856-866.
42. STEINGART K.R., FLORES L.L., DENDUKURI N., SCHILLER I., LAAL S., RAMSAY A., HOPEWELL P.C., PAI M. (2011). Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med. 8, e1001062.
43. TORTOLI E., RUSSO C., PIERSIMONI C., MAZZOLA E., DAL MONTE P., PASCARELLA M., BORRONI E., MONDO A., PIANA F., SCARPARO C., COLTELLA L., LOMBARDI G., CIRILLO D.M. (2012). Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. 40, 442-447.
44. WALZL G., RONACHER K., HANEKOM W., SCRIBA T.J., ZUMLA A. (2011). Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11, 343-354.
45. WEYER K., CARAI S., NUNN P. (2011). Viewpoint TB diagnostics: what does the world really need? J. Infect. Dis. 204 (Suppl. 4): S1196-1202.
46. WEYER K., MIRZAYEV F., MIGLIORI G., VAN GEMERT W., D'AMBROSIO L., ZIGNOL M., FLOYD K., CENTIS R., CIRILLO D., TORTOLI E., GILPIN C., IRAGENA J., FALZON D., RAVIGLIONE M. (2012). Rapid molecular TB diagnosis: evidence, policy-making and global implementation of Xpert(R)MTB/RIF. Eur. Respir. J.
47. World Health Organization, WHO, Global Tuberculosis Control 2008: surveillance, planning, financing. Geneva, Switzerland: WHO. 2008 ISBN 9789241 563543.
48. World Health Organization, WHO, Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis: Policy Statement. Geneva, Switzerland: WHO. 2011-a ISBN 978 92 4 150205 4 (http://whqlib-doc.who.int/publications/2011/ 9789241502054-eng.pdf).
49. World Health Organization, WHO, An International Roadmap for Tuberculosis Research. Geneva, Switzerland: WHO. 2011-b ISBN 978 92 4 150254 2 (http://www.stoptb.org/assets/documents/resources/publications/technical/ tbresearchroadmap.pdf)
50. World Health Organization, WHO, Global tuberculosis report 2012. Geneva, Switzerland: WHO. 2012 ISBN 978 92 4 156450 2 (http://www.who.int/tb/ publications/global-report/gtbr12-main.pdf)